Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Buys 18,226 Shares

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 18,226 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The shares were purchased at an average cost of $0.73 per share, with a total value of $13,304.98. Following the acquisition, the chief executive officer now directly owns 14,966,204 shares of the company’s stock, valued at approximately $10,925,328.92. This trade represents a 0.12 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Retractable Technologies Stock Performance

NYSE:RVP traded up $0.02 during trading hours on Monday, reaching $0.76. The company had a trading volume of 18,091 shares, compared to its average volume of 143,135. Retractable Technologies, Inc. has a 1-year low of $0.56 and a 1-year high of $1.34. The firm has a market cap of $22.75 million, a PE ratio of -1.41 and a beta of 1.94. The business’s 50 day moving average price is $0.66 and its 200-day moving average price is $0.84. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC purchased a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies as of its most recent filing with the Securities & Exchange Commission. 7.58% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Retractable Technologies in a report on Monday, January 6th. They issued a “hold” rating for the company.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.